These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 29705082)

  • 1. Transvenous extraction of advisory implantable cardioverter defibrillator leads with a relatively long implant duration.
    Goya M; Nagashima M; Hiroshima KI; Hayashi K; Makihara Y; Fukunaga M; An Y; Ohe M; Sasaki T; Shiohira S; Shirai Y; Kawabata M; Ando K; Isobe M; Hirao K
    J Cardiol; 2018 Oct; 72(4):316-320. PubMed ID: 29705082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transvenous extraction of implantable cardioverter-defibrillator leads under advisory--a comparison of Riata, Sprint Fidelis, and non-recalled implantable cardioverter-defibrillator leads.
    Brunner MP; Cronin EM; Jacob J; Duarte VE; Tarakji KG; Martin DO; Callahan T; Borek PP; Cantillon DJ; Niebauer MJ; Saliba WI; Kanj M; Wazni O; Baranowski B; Wilkoff BL
    Heart Rhythm; 2013 Oct; 10(10):1444-50. PubMed ID: 23816440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative outcomes of transvenous extraction of sprint fidelis and riata defibrillator leads: a single center experience.
    Richardson TD; Kolek MJ; Goyal SK; Shoemaker MB; Lewis AA; Rottman JN; Whalen SP; Ellis CR
    J Cardiovasc Electrophysiol; 2014 Jan; 25(1):36-42. PubMed ID: 24028661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multicenter experience with extraction of the Riata/Riata ST ICD lead.
    Maytin M; Wilkoff BL; Brunner M; Cronin E; Love CJ; Grazia Bongiorni M; Segreti L; Carrillo RG; Garisto JD; Kutalek S; Subzposh F; Fischer A; Coffey JO; Gangireddy SR; Saba S; Mittal S; Arshad A; O'Keefe RM; Henrikson CA; Belott P; John RM; Epstein LM
    Heart Rhythm; 2014 Sep; 11(9):1613-8. PubMed ID: 24854215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased rate of subacute lead complications with small-caliber implantable cardioverter-defibrillator leads.
    Ellis CR; Rottman JN
    Heart Rhythm; 2009 May; 6(5):619-24. PubMed ID: 19389648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased incidence of subacute lead perforation noted with one implantable cardioverter-defibrillator.
    Danik SB; Mansour M; Singh J; Reddy VY; Ellinor PT; Milan D; Heist EK; d'Avila A; Ruskin JN; Mela T
    Heart Rhythm; 2007 Apr; 4(4):439-42. PubMed ID: 17399630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Comparative Study of Defibrillator Leads at a Large-Volume Implanting Hospital: Results From the Pacemaker and Implantable Defibrillator Leads Survival Study ("PAIDLESS").
    Cohen TJ; Asheld WJ; Germano J; Islam S; Patel D
    J Invasive Cardiol; 2015 Jun; 27(6):292-300. PubMed ID: 26028656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimal management of Riata leads with no known electrical abnormalities or externalization: a decision analysis.
    Pokorney SD; Zhou K; Matchar DB; Love S; Zeitler EP; Lewis R; Piccini JP
    J Cardiovasc Electrophysiol; 2015 Feb; 26(2):184-91. PubMed ID: 25311559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Canadian experience with Durata and Riata ST Optim defibrillator leads: a report from the Canadian Heart Rhythm Society Device Committee.
    Bennett MT; Ha AC; Exner DV; Tung SK; Parkash R; Connors S; Coutu B; Crystal E; Champagne J; Philippon F; Yee R; Stephenson EA; Nery PB; Essebag V; Sanatani S; Redfearn D; Krahn AD; Healey JS
    Heart Rhythm; 2013 Oct; 10(10):1478-81. PubMed ID: 23973950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulse Generator Exchange Does Not Accelerate the Rate of Electrical Failure in a Recalled Small Caliber ICD Lead.
    Lovelock JD; Premkumar A; Levy MR; Mengistu A; Hoskins MH; El-Chami MF; Lloyd MS; Leon AR; Langberg JJ; Delurgio DB
    Pacing Clin Electrophysiol; 2015 Dec; 38(12):1434-8. PubMed ID: 26285670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Update on small-diameter implantable cardioverter-defibrillator leads performance.
    van Rees JB; van Welsenes GH; Borleffs CJ; Thijssen J; van der Velde ET; van der Wall EE; van Erven L; Schalij MJ
    Pacing Clin Electrophysiol; 2012 Jun; 35(6):652-8. PubMed ID: 22352338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective nationwide fluoroscopic and electrical longitudinal follow-up of recalled Riata defibrillator leads in Denmark.
    Larsen JM; Nielsen JC; Johansen JB; Haarbo J; Petersen HH; Thøgersen AM; Hjortshøj SP
    Heart Rhythm; 2014 Dec; 11(12):2141-7. PubMed ID: 25008285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extraction outcomes of implantable cardioverter-defibrillator leads vary by manufacturer and model family.
    Hayashi K; Callahan T; Rickard J; Younis A; Baranowski B; Martin D; Nakhla S; Tabaja C; Wilkoff BL
    Europace; 2023 Dec; 25(12):. PubMed ID: 38000893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lead implant duration does not always predict ease of extraction: extraction sheath may be required at < 1 year.
    Maytin M; Epstein LM; John RM
    Pacing Clin Electrophysiol; 2011 Dec; 34(12):1615-20. PubMed ID: 22017453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lead electrical parameters may not predict integrity of the Sprint Fidelis ICD lead.
    Maytin M; Epstein LM
    Heart Rhythm; 2012 Sep; 9(9):1446-51. PubMed ID: 22537883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome of the Fidelis implantable cardioverter-defibrillator lead advisory: a report from the Canadian Heart Rhythm Society Device Advisory Committee.
    Krahn AD; Champagne J; Healey JS; Cameron D; Simpson CS; Thibault B; Mangat I; Tung S; Sterns L; Birnie DH; Exner DV; Parkash R; Sivakumaran S; Davies T; Coutu B; Crystal E; Wolfe K; Verma A; Stephenson EA; Sanatani S; Gow R; Connors S; Paredes FA; Essebag V;
    Heart Rhythm; 2008 May; 5(5):639-42. PubMed ID: 18452862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of lead failure manifestation of Biotronik Linox with St. Jude Medical Riata and Medtronic Sprint Fidelis lead.
    Lam A; Buehler S; Goulouti E; Sweda R; Haeberlin A; Medeiros-Domingo A; Servatius H; Seiler J; Baldinger S; Noti F; Tanner H; Roten L
    J Interv Card Electrophysiol; 2019 Mar; 54(2):161-170. PubMed ID: 30471050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Major predictors of fibrous adherences in transvenous implantable cardioverter-defibrillator lead extraction.
    Segreti L; Di Cori A; Soldati E; Zucchelli G; Viani S; Paperini L; De Lucia R; Coluccia G; Valsecchi S; Bongiorni MG
    Heart Rhythm; 2014 Dec; 11(12):2196-201. PubMed ID: 25111324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is the transvenous extraction of cardioverter-defibrillator leads more hazardous than that of pacemaker leads?
    Małecka B; Kutarski A; Grabowski M
    Kardiol Pol; 2010 Aug; 68(8):884-90. PubMed ID: 20730717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multi-institutional study of implantable defibrillator lead performance in children and young adults: results of the Pediatric Lead Extractability and Survival Evaluation (PLEASE) study.
    Atallah J; Erickson CC; Cecchin F; Dubin AM; Law IH; Cohen MI; Lapage MJ; Cannon BC; Chun TU; Freedenberg V; Gierdalski M; Berul CI;
    Circulation; 2013 Jun; 127(24):2393-402. PubMed ID: 23694966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.